These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

344 related items for PubMed ID: 36245647

  • 1. Changes in Iron Availability with Roxadustat in Nondialysis- and Dialysis-Dependent Patients with Anemia of CKD.
    Pergola PE, Charytan C, Little DJ, Tham S, Szczech L, Leong R, Fishbane S.
    Kidney360; 2022 Sep 29; 3(9):1511-1528. PubMed ID: 36245647
    [Abstract] [Full Text] [Related]

  • 2. Roxadustat (FG-4592) treatment for anemia in dialysis-dependent (DD) and not dialysis-dependent (NDD) chronic kidney disease patients: A systematic review and meta-analysis.
    Liu J, Zhang A, Hayden JC, Bhagavathula AS, Alshehhi F, Rinaldi G, Kontogiannis V, Rahmani J.
    Pharmacol Res; 2020 May 29; 155():104747. PubMed ID: 32171893
    [Abstract] [Full Text] [Related]

  • 3. Roxadustat (FG-4592) Versus Epoetin Alfa for Anemia in Patients Receiving Maintenance Hemodialysis: A Phase 2, Randomized, 6- to 19-Week, Open-Label, Active-Comparator, Dose-Ranging, Safety and Exploratory Efficacy Study.
    Provenzano R, Besarab A, Wright S, Dua S, Zeig S, Nguyen P, Poole L, Saikali KG, Saha G, Hemmerich S, Szczech L, Yu KH, Neff TB.
    Am J Kidney Dis; 2016 Jun 29; 67(6):912-24. PubMed ID: 26846333
    [Abstract] [Full Text] [Related]

  • 4. Randomized placebo-controlled dose-ranging and pharmacodynamics study of roxadustat (FG-4592) to treat anemia in nondialysis-dependent chronic kidney disease (NDD-CKD) patients.
    Besarab A, Provenzano R, Hertel J, Zabaneh R, Klaus SJ, Lee T, Leong R, Hemmerich S, Yu KH, Neff TB.
    Nephrol Dial Transplant; 2015 Oct 29; 30(10):1665-73. PubMed ID: 26238121
    [Abstract] [Full Text] [Related]

  • 5. The efficacy and safety of roxadustat for anemia in patients with chronic kidney disease: a meta-analysis.
    Zheng Q, Yang H, Fu X, Huang Y, Wei R, Wang Y, Liu YN, Liu WJ.
    Nephrol Dial Transplant; 2021 Aug 27; 36(9):1603-1615. PubMed ID: 33051677
    [Abstract] [Full Text] [Related]

  • 6. Phase 2 studies of oral hypoxia-inducible factor prolyl hydroxylase inhibitor FG-4592 for treatment of anemia in China.
    Chen N, Qian J, Chen J, Yu X, Mei C, Hao C, Jiang G, Lin H, Zhang X, Zuo L, He Q, Fu P, Li X, Ni D, Hemmerich S, Liu C, Szczech L, Besarab A, Neff TB, Peony Yu KH, Valone FH.
    Nephrol Dial Transplant; 2017 Aug 01; 32(8):1373-1386. PubMed ID: 28371815
    [Abstract] [Full Text] [Related]

  • 7. Phase 3, Randomized, Double-Blind, Active-Comparator (Darbepoetin Alfa) Study of Oral Roxadustat in CKD Patients with Anemia on Hemodialysis in Japan.
    Akizawa T, Iwasaki M, Yamaguchi Y, Majikawa Y, Reusch M.
    J Am Soc Nephrol; 2020 Jul 01; 31(7):1628-1639. PubMed ID: 32493693
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. A network meta-analysis of the efficacy of hypoxia-inducible factor prolyl-hydroxylase inhibitors in dialysis chronic kidney disease.
    Chen J, Shou X, Xu Y, Jin L, Zhu C, Ye X, Mei Z, Chen P.
    Aging (Albany NY); 2023 Mar 27; 15(6):2237-2274. PubMed ID: 36988549
    [Abstract] [Full Text] [Related]

  • 13. Roxadustat for Treating Anemia in Patients with CKD Not on Dialysis: Results from a Randomized Phase 3 Study.
    Fishbane S, El-Shahawy MA, Pecoits-Filho R, Van BP, Houser MT, Frison L, Little DJ, Guzman NJ, Pergola PE.
    J Am Soc Nephrol; 2021 Mar 27; 32(3):737-755. PubMed ID: 33568383
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Efficacy and Cardiovascular Safety of Roxadustat for Treatment of Anemia in Patients with Non-Dialysis-Dependent CKD: Pooled Results of Three Randomized Clinical Trials.
    Provenzano R, Szczech L, Leong R, Saikali KG, Zhong M, Lee TT, Little DJ, Houser MT, Frison L, Houghton J, Neff TB.
    Clin J Am Soc Nephrol; 2021 Aug 27; 16(8):1190-1200. PubMed ID: 34362786
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Safe and Effective Treatment for Anemic Patients With Chronic Kidney Disease: An Updated Systematic Review and Meta-Analysis on Roxadustat.
    Tang M, Zhu C, Yan T, Zhou Y, Lv Q, Chuan J.
    Front Pharmacol; 2021 Aug 27; 12():658079. PubMed ID: 34276361
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.